AstraZeneca plc vs EHang Holdings Ltd - ADR — how do they compare? AstraZeneca plc trades at $158.2 (market cap $248.14B), while EHang Holdings Ltd - ADR trades at $5.78 (market cap $437.63M). The key difference: AstraZeneca plc is far larger — about 567× EHang Holdings Ltd - ADR's market cap, and AstraZeneca plc pays a 2.01% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| AZN | EH | |
|---|---|---|
Market Cap | $248.14B | $437.63M |
Sector | Health | Industrials |
52-Week High | $209.48 | $19.44 |
52-Week Low | $147.06 | $4.90 |
Enterprise Value | $275.41B | $376.84M |
Dividend Yield | 2.01% | — |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →